Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.41) by 12.2 percent. This is a 2.13 percent increase over losses of $(0.47) per share from the same period last year.
Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.41) by 12.2 percent. This is a 2.13 percent increase over losses of $(0.47) per share from the same period last year.
Comments